ASAP1 and glioblastoma: Certain circRNAs such as hsa_circ_0076,248, hsa_circ_0043,949 and circ-ASAP1 are involved with TMZ resistance in GBM and can be a potential therapeutic target to restore GBM chemosensitivity to improve patient prognosis [211,233,234].